Market revenue in 2023 | USD 492.8 million |
Market revenue in 2030 | USD 749.3 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Preserved multi-dose eye droppers |
Fastest growing segment | Preservative-free multi-dose eye droppers |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Unidose eye droppers, Preserved multi-dose eye droppers, Preservative-free multi-dose eye droppers |
Key market players worldwide | AptarGroup Inc, Silgan Holdings Inc, Alcon Inc, Pfizer Inc, Bausch & Lomb Corp, Novartis AG ADR, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic eye droppers market will help companies and investors design strategic landscapes.
Preserved multi-dose eye droppers was the largest segment with a revenue share of 49.94% in 2023. Horizon Databook has segmented the Japan ophthalmic eye droppers market based on unidose eye droppers, preserved multi-dose eye droppers, preservative-free multi-dose eye droppers covering the revenue growth of each sub-segment from 2018 to 2030.
DED stands as a significantly prevalent ophthalmic condition in Japan. Accurate diagnosis and assessment are crucial for doctors to provide appropriate treatment to individuals affected by this ailment. Consequently, the rising prevalence of various eye-related disorders in the country is expected to drive the adoption of ophthalmic eye droppers as a preferred treatment option.
In addition, favorable health insurance and reimbursement policies help strengthen Japanese healthcare services. For instance, the National Health Insurance (NHI) is mandatory for every citizen in Japan and most healthcare expenditure is government funded.
Several public initiatives to control spending, such as preventive care, self-management of eye diseases, and the use of generic drugs, have been initiated. Such measures are expected to drive the ophthalmic eye droppers market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan ophthalmic eye droppers market , including forecasts for subscribers. This country databook contains high-level insights into Japan ophthalmic eye droppers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account